Once-a-week or every-other-day urethra-sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow-up results.

Zilli T., Jorcano S., Bral S., Rubio C., Bruynzeel A., Oliveira A., ...Daha Fazla

Cancer medicine, cilt.9, sa.9, ss.3097-3106, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 9 Sayı: 9
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1002/cam4.2966
  • Dergi Adı: Cancer medicine
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, Directory of Open Access Journals
  • Sayfa Sayıları: ss.3097-3106
  • Anahtar Kelimeler: overall treatment time, prostate cancer, quality of life, stereotactic body radiotherapy, urethra sparing
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet